JAMES R III GAVIN

CIK 1220966 · President and CEO · last filed 2020-09-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$909.9K

Companies

3

Total Filings

106

Lifetime Open-Market Net

-$5.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BAX Director 43,618 $20.86 $909.9K -$5.10M 68 2020-09-15
Baxalta Inc (BXLT) Delisted Director 30,747 -$226.2K 4 2016-05-12
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Director 4,580 -$10.0K 29 2012-05-24

Recent Filings · Page 5 of 11

106 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-05-09 BAX Grant (A) +1,600 $0 EDGAR
2013-04-30 BAX Grant (A) $0 EDGAR
2013-03-04 BAX Mixed -$460.0K EDGAR
2013-02-01 BAX Exer (M) +2,500 $70.2K EDGAR
2013-01-29 BAX Grant (A) $0 EDGAR
2013-01-04 BAX Disc (I) $0 EDGAR
2012-10-26 BAX Grant (A) $0 EDGAR
2012-08-10 Mixed −4,580 -$142.0K
2012-08-09 BAX Grant (A) $0 EDGAR
2012-05-24 AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Mixed −3,000 $0 EDGAR
Showing 4150 of 106
Page 5 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.